Carrër A, Turban S, Provost N, Caliez A, Lamarche G, Zanirato G, Beucher M, Pean C, Mirguet O, Perron-Sierra F, Michelet V. Juniperanol: First total synthesis and evaluation in Type 2 Diabetes disease.
Bioorg Chem 2019;
92:103243. [PMID:
31518756 DOI:
10.1016/j.bioorg.2019.103243]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2019] [Revised: 08/31/2019] [Accepted: 08/31/2019] [Indexed: 01/19/2023]
Abstract
The first total synthesis of juniperanol, the tricyclic sesquiterpenoid enantiomer of α-cedrol is described. The synthesis relies on stereoselective gold-catalyzed Ohloff-type propargylic ester rearrangement performed on a 10 g scale, and a carbocationic cascade in the presence of acetyl methanesulfonate. The ability of juniperanol to interfere in glucose processes in different cell types is described.
Collapse